Results 171 to 180 of about 3,126,496 (202)
Some of the next articles are maybe not open access.

Management of Essential Thrombocythemia

Hematology, 2011
Abstract Essential thrombocythemia (ET) is a Philadelphia chromosome (Ph)–negative myeloproliferative neoplasm (MPN) characterized by thrombocytosis and megakaryocytic hyperplasia of the bone marrow, with presence of the JAK2 V617F mutation in 50%-60% of patients. ET evolves to myelofibrosis in a minority of cases, whereas transformation
openaire   +2 more sources

Pipobroman therapy of essential thrombocythemia

European Journal of Haematology, 1986
We report our results with pipobroman (PB) therapy in patients with essential thrombocythemia (ET). 21 consecutive untreated patients were treated with PB from 1975 to 1984. PB was given at a dose of 1 mg/kg/d until platelet count dropped below 600 × 109/l. In 18 patients (86%) a hematological remission was obtained.
MAZZUCCONI, Maria Gabriella   +6 more
openaire   +3 more sources

The pathogenesis of essential thrombocythemia

Current Opinion in Hematology, 2011
The identification of new mutations continues to further our understanding of the molecular pathogenesis of essential thrombocythemia and related disorders, and offers opportunities for improvements in diagnosis, risk stratification and disease classification.Molecular lesions in essential thrombocythemia affect two distinct pathways: cytokine ...
openaire   +2 more sources

ESSENTIAL THROMBOCYTHEMIA

Annals of Internal Medicine, 1958
H G, KUPFER   +4 more
openaire   +2 more sources

Essential Thrombocythemia

The Journal for Nurse Practitioners, 2023
Ruth Madden Foreman, Richard Brzustowicz
openaire   +1 more source

Essential Thrombocythemia

2018
Susmitha Apuri, Kenneth Zuckerman
  +5 more sources

Current Management Strategies for Polycythemia Vera and Essential Thrombocythemia

Blood Reviews, 2020
Alessandro Maria Vannucchi   +1 more
exaly  

Hydroxyurea Compared With Anagrelide in High-Risk Essential Thrombocythemia

New England Journal of Medicine, 2005
Anthony R Green   +2 more
exaly  

Hydroxyurea for Patients With Essential Thrombocythemia and a High Risk of Thrombosis

New England Journal of Medicine, 1995
Marco Ruggeri   +2 more
exaly  

When and How to Treat Essential Thrombocythemia

New England Journal of Medicine, 2005
Tiziano Barbui, Guido Finazzi
exaly  

Home - About - Disclaimer - Privacy